標(biāo)題: Titlebook: Rare Diseases in the Age of Health 2.0; Rajeev K. Bali,Lodewijk Bos,Simon Ibell Book 2014 Springer-Verlag Berlin Heidelberg 2014 Disease D [打印本頁] 作者: MASS 時間: 2025-3-21 18:37
書目名稱Rare Diseases in the Age of Health 2.0影響因子(影響力)
書目名稱Rare Diseases in the Age of Health 2.0影響因子(影響力)學(xué)科排名
書目名稱Rare Diseases in the Age of Health 2.0網(wǎng)絡(luò)公開度
書目名稱Rare Diseases in the Age of Health 2.0網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Rare Diseases in the Age of Health 2.0被引頻次
書目名稱Rare Diseases in the Age of Health 2.0被引頻次學(xué)科排名
書目名稱Rare Diseases in the Age of Health 2.0年度引用
書目名稱Rare Diseases in the Age of Health 2.0年度引用學(xué)科排名
書目名稱Rare Diseases in the Age of Health 2.0讀者反饋
書目名稱Rare Diseases in the Age of Health 2.0讀者反饋學(xué)科排名
作者: GENUS 時間: 2025-3-21 22:51 作者: 樹木心 時間: 2025-3-22 03:48 作者: dainty 時間: 2025-3-22 08:23 作者: indigenous 時間: 2025-3-22 11:25 作者: Inflamed 時間: 2025-3-22 13:14 作者: NUDGE 時間: 2025-3-22 19:15
https://doi.org/10.1007/978-3-642-38643-5Disease Data Mining; Electronic Health Records; Electronic Health Records; Genomics and Biotechnology; H作者: 小說 時間: 2025-3-22 21:25 作者: 委屈 時間: 2025-3-23 04:42 作者: 混雜人 時間: 2025-3-23 08:53
Rajeev K. Bali,Lodewijk Bos,Simon IbellFocuses on various factors associated with orphan diseases.Highlights the opportunities and challenges through information technologies and Health 2.0.Explores economic possibilities.Written by an int作者: 發(fā)酵劑 時間: 2025-3-23 12:08 作者: 堅(jiān)毅 時間: 2025-3-23 16:35 作者: COUCH 時間: 2025-3-23 21:54 作者: 根除 時間: 2025-3-23 22:47
Amanda Lordemann,Krissi Danielsson,Jimmy Cheng-Ho Lin作者: Resection 時間: 2025-3-24 05:10
Why R&D into Rare Diseases Matterheless been made in rare disease understanding. I will show that translation of rare disease research into orphan drug development represents one of the most important steps towards alleviating the burden for patients suffering from a rare disease. Moreover, developing an orphan drug is certainly fe作者: forbid 時間: 2025-3-24 06:54
Innovative Funding Models for Rare Diseasese these aspects to advance understanding and progress towards a cure for all 7,000 rare diseases. Because these projects are unique and often do not fit into existing grants, a web page for each patient is created and the funds collected go directly to the research for that patient. This chapter dis作者: 大都市 時間: 2025-3-24 12:10 作者: Iniquitous 時間: 2025-3-24 18:55
Vignette: A Giant of a Man: Simon Ibell (MPS II)as a darkness that was lonely and intense. In those moments, I realized I was allowing the fear of my son suffering or dying to potentially stifle his wonderful spirit and that spirit would be the determining factor in his life: his defiance.作者: Hiatal-Hernia 時間: 2025-3-24 19:35
Social Media and Engaging with Health Providersients and clinicians who are geographically dispersed, such as those working in the field of rare and orphan diseases. Different applications of these tools emerge frequently and technological developments will provide increasingly better platforms for patients and clinicians to collaborate and engage to improve health outcomes.作者: Repetitions 時間: 2025-3-25 01:54 作者: ADORN 時間: 2025-3-25 04:23 作者: Alpha-Cells 時間: 2025-3-25 11:17
Book 2014.0, and highlights also economic opportunities of orphan disease medicine. The editors of this new book have international experience and competencies in the key areas of patient empowerment, healthcare and clinical knowledge management, healthcare inequalities and disparities, rare diseases and patient advocacy.作者: Sputum 時間: 2025-3-25 13:44
Health 2.0 and Information Literacy for Rare and Orphan Diseasesth information and emotional support for people with rare diseases. Areas currently being given consideration for future coordination are briefly reviewed as part of the development of information literacy in rare and orphan diseases.作者: Gourmet 時間: 2025-3-25 19:37
Why R&D into Rare Diseases Matteres are not confined to Europe and the US, but affect people all over the world, and consequently represent a true global health issue. As such there can be no doubt that R&D into rare diseases matter. Specific orphan drug legislations across the globe have been introduced to stimulate the pharmaceut作者: OMIT 時間: 2025-3-25 23:57
Vignette: Autoimmune Polyendocrine Syndrome Type I (APS 1)sively, in the endocrine system. It is a genetic disorder associated with a defect in the . gene. Currently, it is believed that APS 1 attacks one in 2,000,000 people: approximately 17 in Canada, and 160 or so in the United States. While it can attack many tissues in the body, it is best known as a 作者: 停止償付 時間: 2025-3-26 01:58
Rare Diseases: How Genomics has Transformed Thinking, Diagnoses and Hope for Affected Families genome sequencing and whole exome sequencing of genomes—to diagnose phenotypically complex monogenic diseases in a significant number of cases. A pan-Canadian initiative launched in 2011 (FORGE) has developed a highly sophisticated and productive pipeline that has identified the causative genes for作者: 鉗子 時間: 2025-3-26 06:41
Vignette: A Giant of a Man: Simon Ibell (MPS II)s later before I felt the pain of hearing that Simon had a rare and incurable disease: MPS II or Hunter Syndrome. A few minutes of doctor’s explanation and my world came crashing down; I was powerless to express the simplest words, I wanted to scream. As I left that meeting with the doctors, there w作者: Lyme-disease 時間: 2025-3-26 08:34
Innovative Funding Models for Rare Diseasese disease research, it is a very difficult task for a central, top–down entity to create and fund research for so many different diseases. With the traditional research model, therapies have been developed for less than 500 of these diseases, meaning that more than 9 in 10 diseases do not have any t作者: 勉強(qiáng) 時間: 2025-3-26 16:18
Rare Diseases: The Medical and the Disability Perspectives in the Age of 2.0improve the visibility and hence research on rare diseases by examining how they are conceptualized and represented in contemporary health care communities. Such conceptualizations are framed in terms of two models, the medical model, which prevails in the medical and scientific literature, and the 作者: SMART 時間: 2025-3-26 20:23
Vignette: Taking Control of Thalassemia was a happy-go-lucky baby, always smiling and moving her arms around. Then, one day I noticed a difference. I went to a party and saw another baby her age there, laughing and so happy. I thought about how Cassandra was usually as happy, but that lately, she cried more often and just seemed lethargi作者: NICHE 時間: 2025-3-26 22:20
Industry Perspectives on Orphan Drug Developmentvelopment in biotechnology, the various factors necessary for commercializing orphan drug candidates, phases and trials of clinical development and factors which may affect commercialization of a product. The chapter concludes with implications for patients and families.作者: 要塞 時間: 2025-3-27 01:37 作者: indifferent 時間: 2025-3-27 09:12 作者: narcotic 時間: 2025-3-27 10:47
Health 2.0 and Information Literacy for Rare and Orphan Diseasesticular, the chapter uses a real life case study to consider the information experience of a person in the early stages of a rare condition, both pre and post diagnosis. It also reviews the information experience of the health professionals responsible for their care. The chapter addresses common ba作者: 到婚嫁年齡 時間: 2025-3-27 17:11
Social Media and Engaging with Health Providersarch and patient support. While social media use in healthcare is currently in its infancy, there is enormous potential for applications dedicated to accessing health information, specialist clinical knowledge and participating in the latest research initiatives. These benefits are amplified for pat作者: 是限制 時間: 2025-3-27 20:04 作者: 緩和 時間: 2025-3-28 00:30
The Role of Social Media in Healthcare: Experiences of a Crohn’s Disease Patientmporary IT tools and techniques can be used effectively to actively engage patients in their own care. Examples of patient-to-patient interaction via new social media are provided. The concept of the “i-patient” is introduced and the need to empower both patients and healthcare professionals is sugg作者: 失望未來 時間: 2025-3-28 06:06 作者: OMIT 時間: 2025-3-28 09:15 作者: Anticlimax 時間: 2025-3-28 10:28 作者: 真 時間: 2025-3-28 14:51
2191-3811 Health 2.0.Explores economic possibilities.Written by an intThis text focuses on various factors associated with orphan diseases and the influence and role of health information technologies. Orphan diseases have not been adopted by the pharmaceutical industry because they provide little financial i作者: 消毒 時間: 2025-3-28 19:33
Donald G. McFetridge physicians and often present significant diagnostic challenges. Our goal in writing this short book was to provide easily accessible information in a pocket-sized format. We hope we have helped both the g- eral rheumatologist who only encounter these problems occasionally. We have focused on clinic作者: 有危險 時間: 2025-3-29 02:43 作者: hypertension 時間: 2025-3-29 05:09 作者: 門窗的側(cè)柱 時間: 2025-3-29 08:50
,Update on Bromocriptine in Parkinson’s Disease,tain this response and become more symptomatic. Increasing disability is usually accompanied by dyskinesias and diurnal fluctuations in performance, predominantly “wearing-off” phenomena (. and . 1977; 1976). Occasionally, patients exhibit abrupt random fluctuations: “on-off” phenomena.作者: 責(zé)問 時間: 2025-3-29 13:51
Learning, Working and Living: An Introductionlearning organization’ have contributed to the growing debate about the nature of learning at work. Identifying ways in which learning can be supported in the workplace has been a long-standing concern within the organization studies and education literatures alike. What perhaps is particularly inte作者: 免費(fèi) 時間: 2025-3-29 18:56 作者: 真繁榮 時間: 2025-3-29 22:05 作者: Laconic 時間: 2025-3-30 01:58 作者: 運(yùn)動性 時間: 2025-3-30 06:54 作者: 調(diào)整校對 時間: 2025-3-30 09:17 作者: 珠寶 時間: 2025-3-30 13:53
Pathogenese des Typ-1-Diabetes mellitus,printing in human neoplasia. We describe data linking three imprinted genes on chromosome 11p15.5, ., and ., to the pathogenesis of Wilms’ tumor (WT) and other neoplasms, as well as to the fetal overgrowth associated with the Beckwith-Wiedemann Syndrome(BWS). We discuss evidence for epimutations at 作者: 咯咯笑 時間: 2025-3-30 17:21 作者: IST 時間: 2025-3-31 00:17
Engineered OAKs Against Antibiotic Resistance and for Bacterial Detectionhundreds of analogs, we describe the properties of a few representative lysyl-based OAC (OAK) sequences. These sequences reflect the OAC concept evolution from the original focus on bactericidal MACs that later shifted onto bacteriostatic derivatives and presently concentrates on seemingly inactive 作者: objection 時間: 2025-3-31 04:21
..Assessment of Power System Reliability. has been written in straightforward language that continues into the mathematical representation of the methods. Power engineers and developers will978-1-4471-6100-4978-0-85729-688-7作者: eulogize 時間: 2025-3-31 05:49 作者: nonradioactive 時間: 2025-3-31 13:06
Water, State and the City978-1-137-46867-3Series ISSN 2946-3459 Series E-ISSN 2946-3467 作者: 一罵死割除 時間: 2025-3-31 17:14
